About ACT
ACT is a venture capital firm founded in 2015. It is primarily based out of London, United Kingdom. As of Apr 2026, ACT is an active investor, having invested in 22 companies, with 1 new investment in the last 12 months. It primarily invests in Seed round in Turkey based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Auto Tech. Most recently it participated in the $***** Seed round of Qubitrium Overall, ACT portfolio has seen 1 unicorn and 2 acquisitions, namely Carbon Health, Segmentify and Hazy. A lot of funds co-invest with ACT, with names like Hirschvogel Automotive Group sharing a substantial percentage of its portfolio. ACT has team of 15 people including 5 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed & Series A
Portfolio Acquisitions
Portfolio Unicorns
Deals in last 12 months
ACT's List of Top Investments
ACT has a portfolio of 22 companies, one of which is a Unicorn. Their most notable investments are in RS Research and Ambeent.Their portfolio spans across Turkey, United States, United Kingdom and 2 more locations. They have invested in Enterprise Applications, High Tech, Auto Tech and 16 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by ACT:
Provider of a wide range of healthcare services. The platform allows patients to book appointments, message provider, view health history, and manage prescriptions all in one place. Users can also order diagnostic tests and medicines at home.
Key facts about Carbon Health
- Founded Year: 2015
- Location: Seattle (United States)
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $614M
- Employee Count: 1,079 as on Sep 30, 2026
- Investors: Silver Lake, Dragoneer Investment Group and 66 Others
- Latest Funding Round: Series D, Jan 09, 2023, $*****
- Highlight: Editors' Pick
2. Segmentify
Cloud-based product personalization tool for omnichannel retailers. It recommends products to website visitors as per their behavior and performance analytics. It also provides a cart content optimization engine and an alternative product recommendation engine.
Key facts about Segmentify
- Founded Year: 2015
- Location: Istanbul (Turkey)
- Stage: Acquired
- Total Funding till date: $8M
- Employee Count: 65 as on Sep 30, 2026
- Investors: Koc Holding, Sabancı Ventures and 10 Others
- Latest Funding Round: Seed, Jul 12, 2023, $*****
- Highlight: Acquired
Provider of a platform for security validation and exposure management. The platform offers security control, attack surface, and cloud security validation. It features attack path and detection rule validation, along with integrations. The platform helps discover, evaluate, and prioritize vulnerabilities and misconfigurations. It consolidates security data to improve decision-making and operational efficiency. The platform simulates attacks to measure and optimize security controls.
Key facts about Picus Security
- Founded Year: 2013
- Location: Ankara (Turkey)
- Stage: Series C
- Total Funding till date: $80M
- Employee Count: 315 as on Sep 30, 2026
- Investors: Earlybird, Riverwood Capital and 8 Others
- Latest Funding Round: Series C, Sep 19, 2024, $*****
- Highlight: Editors' Pick
4. Eatron
AI and cloud-enabled battery management and motion control system. The company develops AI-enabled battery management system and model based motion control system. It uses various technology like cloud, AI and more.
Key facts about Eatron
- Founded Year: 2017
- Location: Warwick (United Kingdom)
- Annual Revenue: £0 - £1M as on Dec 31, 2024
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $15.1M
- Employee Count: 50 as on Aug 31, 2026
- Investors: MMC Ventures, LG Technology Ventures and 14 Others
- Latest Funding Round: Series A, Jan 18, 2024, $*****
- Highlight: Editors' Pick
5. RS Research
Developer of smart nanomedicines and targeted oncology therapies using polymer-drug conjugate platforms. This biotechnology company focuses on disrupting the efficacy-toxicity trade-off in cancer treatment through the creation of targeted chemotherapy and theranostics. By utilizing advanced delivery platforms, the company aims to improve the therapeutic index across a spectrum of payloads to address challenges in oncology. PF = Yes
Key facts about RS Research
ACT's Year-on-Year Investment Trends
ACT has invested in 22 companies over the last 10 years, with an average of 2 new investments annually in the last 10 years. In 2025, it made 2 investments, while as of Apr 2026, it has made 2 investments in this year. Its most recent first time investment was in Cellbricks Therapeutics and most recent follow-on round was in Qubitrium.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 1 | 2 |
2025 | 1 | 1 | 2 |
2024 | 2 | 0 | 2 |
2023 | 3 | 1 | 4 |
2022 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
2020 | 0 | 0 | 0 |
2019 | 0 | 0 | 0 |
2018 | 1 | 1 | 2 |
2017 | 6 | 0 | 6 |
ACT's Investments by Stage
ACT has made 13 investments in Seed stage with an average round size of $1.71M and 5 investments in Series A stage with an average round size of $8.66M.Stage of entry | No. of Investments |
|---|---|
Seed | 13 |
Series A | 5 |
Note: We have considered here, only first round of investments
ACT's Investments by Sector
ACT has a diverse portfolio, with companies operating in the Enterprise Applications, High Tech, Vertical SaaS, Life Sciences and Industrial Goods and Manufacturing. Notably, it has invested in 21 Tech companies, 17 Enterprise (B2B) companies, 15 Software companies and at least 13 companies focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 12 |
High Tech | 7 |
Vertical SaaS | 5 |
Life Sciences | 4 |
Industrial Goods and Manufacturing | 3 |
Others | 19 |
Note: We have considered here, only first round of investments
ACT's Investments by Geography
ACT has made most investments in Turkey (6), followed by United Kingdom where it has made 5 investments.Country | No. of Investments |
|---|---|
Turkey | 6 |
United Kingdom | 5 |
United States | 4 |
Germany | 1 |
Spain | 1 |
Note: We have considered here, only first round of investments
ACT's recent investments
ACT has made 2 investments in 2026 so far - Qubitrium and Cellbricks Therapeutics.Here are the most recent investments by ACT:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 23, 2026 | - | Seed | 8147 | ||
Mar 25, 2026 | Germany | Seed | 5549 | ||
Dec 17, 2025 | United Kingdom | Series A | 2057 | [+4] | |
Sep 29, 2025 | United States | Series A | 9054 | [+4] | |
Sep 16, 2024 | - | Seed | 7997 | - |
Unicorns in ACT's Portfolio
ACT has 1 unicorn in its portfolio - Carbon Health. The most recent unicorn in their portfolio is Carbon Health which became a unicorn in 2021, 5 years before ACT first invested in it.Here is a list of unicorns in ACT's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
76 | Provider of a wide range of healthcare services | 2015 | Seattle | Series D | gvlggwz |
Acquired companies in ACT's Portfolio
2 companies from ACT's portfolio have been acquired. The most recent acquisition was Segmentify in Jun 2026 by Unifonic for $*****.Here are ACT's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 10, 2026 | Jun 06, 2016 | Seed | 1269 | |
Nov 12, 2024 | Mar 28, 2023 | Series A | 5006 |
Team profile of ACT
ACT has a team of 15 members including 5 Partners and 7 Venture Partners located in Turkey, United Kingdom and 4 more locations. ACT's team sits on the board of 1 company.Here is a list of top team members in ACT:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Hilversum | |||
Partner | London | - | ||
Partner | Istanbul | - | - | |
Partner | Ankara | - | - | |
Partner | Ankara | - | - | |
Venture Partner | Eindhoven | - | - | |
Venture Partner | London | - | ||
Venture Partner | Bulgaria | - | - | |
Venture Partner | San Mateo | - | - | |
Venture Partner | Erlangen | - | - |
Co-investors of ACT
Over the past 10 years, 79 investors have co-invested in ACT's portfolio companies. This includes funds and angels.
- Invested before ACT: StartersHub, Europa and 18 others have invested in rounds before ACT. There are 2 companies where StartersHub has invested before ACT and 2 companies where Europa has invested before ACT.
- Top Co-investors of ACT: 28 investors entered a company along with ACT. These include investors like Hirschvogel Automotive Group (1 company).
- Invested after ACT: A total of 31 investors have invested in ACT's portfolio after their investments. Top Investors include Europa (3 companies), Trkiye Kalknma Fonu (2 companies) and 212 Vc (2 companies).
Recent News related to ACT
•
Qubitrium Secures €2.25M in Seed-Plus Funding to Scale Space-Based Quantum HardwareQuantum Computing Report•Apr 24, 2026•Qubitrium, ACT, Trkiye Kalknma Fonu
•
Cellbricks Therapeutics Raises €10M in FundingFinSMEs•Mar 26, 2026•Cellbricks Therapeutics, ACT, Silicon Roundabout Ventures, SPRIND
•
Aibuild Secures Investment from Driventure and 212 NexT to 3D Printing Industry•Dec 17, 2025•Ai Build, Driventure, Force Over Mass, Atlas Venture and 5 others
•
NxLite raises $9.2M to expand production of energy-control window coatingsVending Times•Oct 14, 2025•Nxlite, Earth Foundry, ACT, New Climate Ventures and 1 other
•
•
Meddenovo secures €1M Pre-Seed to unlock cyclic peptides' drug development potentialTech.eu•Jul 31, 2024•Meddenovo, ACT
•
Nextmol Closes A Round Leaded By Act. Axon, Abac Nest And Grow Venture ParticipateWebcapitalriesgo•May 28, 2024•NEXTMOL, ACT, Grow Venture Partners, Abac Capital and 4 others
•
•
Spotted Zebra secures £7.7m in Series AStartbase•Oct 31, 2023•Spotted, Nauta Capital, Act Venture Capital, Playfair Capital and 4 others
•
Ai Build raises $8.5M to make manufacturing easy and affordable with AITech Funding News•Oct 19, 2023•Ai Build, IQ Capital, Nikon, SuperSeed and 4 others
